Top‐down mass spectrometry and hydrogen/deuterium exchange for comprehensive structural characterization of interferons: Implications for biosimilars
- 26 February 2014
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 14 (10) , 1249-1258
Abstract
Rapid development in biopharmaceuticals has put high demands on analytical tools that can provide accurate and comprehensive characterization of protein drugs, including biosimilars. Although the enzyme digestion based “bottom‐up” approach is usually the method of choice for this purpose, it only gives peptide‐level information and sequence coverage is often incomplete. In this work, we used top‐down MS with electron capture dissociation (ECD) to characterize both the primary and higher order structures of a therapeutic protein interferon and its variants. Accurate mass measurement at the intact protein level combined with top‐down ECD fragmentation enabled unambiguous protein sequence confirmation and identification of all PTMs. Combining hydrogen/deuterium exchange and rapid disulfide reduction with top‐down ECD on the LC time scale, we have investigated the differences in higher order structure between the protein variants, as well as the impact of PTMs on protein conformation.Keywords
Funding Information
- Genome Canada and Genome BC
- Science and Technology Innovation Centre
- UVic-Genome BC Proteomics Centre
This publication has 47 references indexed in Scilit:
- The impact of mass spectrometry on the study of intact antibodies: from post-translational modifications to structural analysisChemical Communications, 2012
- Analytical tools for characterizing biopharmaceuticals and the implications for biosimilarsNature Reviews Drug Discovery, 2012
- Biosimilar, Biobetter, and Next Generation Antibody Characterization by Mass SpectrometryAnalytical Chemistry, 2012
- Biosimilars—why terminology mattersNature Biotechnology, 2011
- Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor BindingMolecular & Cellular Proteomics, 2010
- Characterization of IgG1 Conformation and Conformational Dynamics by Hydrogen/Deuterium Exchange Mass SpectrometryAnalytical Chemistry, 2009
- Protein therapeutics: a summary and pharmacological classificationNature Reviews Drug Discovery, 2008
- Characterization of Variable Regions of Monoclonal Antibodies by Top-Down Mass SpectrometryAnalytical Chemistry, 2007
- Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticalsMass Spectrometry Reviews, 2007
- Billion dollar babies—biotech drugs as blockbustersNature Biotechnology, 2007